To explore whether gM potentiates the efficacy of cancer vaccines through the action of NK cells, we depleted NK cells in tumor-bearing mice using an anti-PK136 antibody via intraperitoneal injection (Fig. 3A, B). The gene discussed is PPP1R3A; the disease is cancer.